Homöopathie im Fokus der GKV-Finanzierungskommission

black apple with slice cut out
Eine Einordnung aus Sicht des INH Das Informationsnetzwerk Homöopathie (INH) nimmt mit einer gewissen Überraschung zur Kenntnis, dass ein mögliches Ende der GKV-Kassenerstattung für die Homöopathie in den jüngsten Äußerungen des Bundesministeriums für Gesundheit prominent …

Kassenerstattung für Homöopathie vor dem Aus! Oder …?

facade of bundestag
Ort der Entscheidung - Photo by Paul Scheelen on Pexels.com Seit Januar wurde es als ziemlich sicher gehandelt, dass mit dem neuen Gesundheitsversorgungsstärkungsgesetz (GVSG) die Erstattung von Homöopathieleistungen (Mittel und Therapie) in der gesetzlichen Krankenversicherung …

Homeopathy in Switzerland – breaking the ice?

snow capped moutain
Photo by Rafa De on Pexels.com It has been a strange and tortuous path that the debate on "complementary medicine" in the Swiss public health system has taken over the last 20 years, leading to …

Time for action! INH Open Letter on Homeopathy in the Health Sector

Six years of INH educational work, discussions and advertising for an appropriate role for homeopathy - not as medicine and outside the health system. We have achieved a lot, raised general awareness about the real …

In the patient’s interest – An interview with Prof. Dr Lars Bräuer

Prof. Lars Bräuer, together with the doctor and medical journalist Falk Stirkat, has just published the book "Der belogene Patient - Warum Impfkritiker, Wunderheiler und andere Scharlatane gefährlicher sind als jedes Virus" (The lied patient …

Corona, Krankenkassen und Homöopathie – Nichts ist immer noch zu teuer!

Viele (alle?) Krankenkassen verschicken derzeit Erhöhungsmitteilungen zu den Beiträgen im Jahre 2021. Die Mehrkosten infolge der Corona-Krise werden vielfach als (Teil-)Begründung angegeben, fraglos ist das zutreffend und soll hier auch nicht Gegenstand der Kritik sein. …

Neue Securvita-Studie in Sachen Homöopathie – spektakulär oder business as usual?

„Was sagen Sie zu der Studie von der Securvita? Da steht doch jetzt wirklich schwarz auf weiß, dass ....“ Diese in letzter Zeit häufiger an uns herangetragene Frage nimmt Bezug auf eine Studie, über die …

“So okay” – no way, Minister Spahn! – A “Too long – Didn’t read” for those in a hurry.

Prof. Tina Salomon's detailed article on the "homeopathic 20-million peanuts", which we recently published under the heading "Points of View", met with great interest - and the desire to provide a "short version" of it. …

“So okay”, Minister Spahn? – No way! – A guest article by health economist Prof. Dr. Tina Salomon

Health economics is an established science. It provides the basis for how modern health care systems function in themselves and in economic environments. It defines a framework for decisions on sustainable health policy under the …

Open letter to Karin Maag, Member of the Bundestag – Reimbursement of Homeopathy

Mrs. Karin Maag, member of the Health Committee of the German Bundestag, has recently spoken out on several occasions against the reimbursement of homeopathy by the statutory health insurance funds. She did use a number …

Open letter of the INH to the German Federal Minister of Health on the “internal consensus” of the German medical law

Yesterday, on 13.06.2019, German TV satirist Jan Böhmermann so satirically as accurately analysed homeopathy in his programme "Neo Magazin Royale" and thus articulated in his special way the - in our opinion -  widespreaded displeasure …

Glasses, dentures and homeopathy – The role of German statutory health insurances

This text describes the legal situation under which health insurance companies in Germany are legally allowed to reimburse costs for homeopathy. Due to the very specific German factual and legal situation, we refrain from a …

Alternative practitioners on pharmacy-only obligation and labelling of homeopathic remedies – a statement of the INH

English version will appear soon.

Open letter of the INH to the Siemens health insurance company (SBK)

In the context of the discussion on the reimbursement of homeopathy by statutory health insurance funds, the CEO of SBK drew attention to himself on Twitter with the "argument" that the small amount spent on …

On homeopathy cost studies: Nothing is always too expensive

The homeopathy advocates and also the health insurers who have included reimbursements for homeopathy in their statutory benefits like to claim that the use of homeopathy shows a cost advantage over science-based remedies and methods. …

Open letter of the information network homeopathy to the statutory health insurance “Die Techniker” (TK)

English version will appear soon.

But health insurance companies wouldn’t pay for ineffective drugs!

(This contribution describes the legal situation in Germany which currently applies to the reimbursement of homeopathy by the statutory health insurance.) Unfortunately the health insurances do this indeed, even if one hardly considers it possible. …
Top